Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-043360
Filing Date
2025-05-14
Accepted
2025-05-14 16:30:58
Documents
56
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241638-10q_citius.htm   iXBRL 10-Q 611422
2 CERTIFICATION ea024163801ex31-1_citius.htm EX-31.1 8775
3 CERTIFICATION ea024163801ex31-2_citius.htm EX-31.2 8839
4 CERTIFICATION ea024163801ex32-1_citius.htm EX-32.1 4112
  Complete submission text file 0001213900-25-043360.txt   4340413

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ctxr-20250331.xsd EX-101.SCH 40404
6 XBRL CALCULATION FILE ctxr-20250331_cal.xml EX-101.CAL 33688
7 XBRL DEFINITION FILE ctxr-20250331_def.xml EX-101.DEF 207529
8 XBRL LABEL FILE ctxr-20250331_lab.xml EX-101.LAB 376169
9 XBRL PRESENTATION FILE ctxr-20250331_pre.xml EX-101.PRE 219472
58 EXTRACTED XBRL INSTANCE DOCUMENT ea0241638-10q_citius_htm.xml XML 393044
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 25946292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)